CompletedNot Applicable

A Performance Study of (Opportunistic) Salpingectomy

Belgium115 participantsStarted 2022-12-09

Plain-language summary

The goal of this clinical trial is to test the quality of the performance of opportunistic salpingectomies in women scheduled for adnexectomy. The main questions it aims to answer are: * How many salpingectomies are incomplete? * Are there any factors related to incomplete resection? Could the investigators develop a instruction video to optimize the surgical technique? Participants planned for uni-or bilateral adnexectomy (removal of ovary and salpinx) will have their adnexectomy in two steps in the same surgical episode: first the salpingectomy (removal of the salpinx), then the oophorectomy (the removal of the ovary).

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients scheduled for uni- or bilateral adnexectomy. (may be in combination with hysterectomy) AND \* competent to act on itself * dutch speaking * signed informed consent Exclusion Criteria: \* Endometrial cancer or invasive cervical cancer * radiotherapy in the pelvis in the medical history * (partial) salpingectomy * Pelvic Inflammatory Disease * Adnexectomy for gender transformation surgery if wish to preserve the ovarian tissue. * Surgery in two steps is not safe to perform * Pregnancy

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1This trial studied how often salpingectomies were done incompletely — what does an incomplete salpingectomy mean in practice, and could that affect my cancer risk or treatment outcomes?
2Since this study focused on 'opportunistic' salpingectomy — meaning removing the fallopian tubes during another planned surgery — is that something worth considering if I'm already scheduled for a pelvic procedure?
3The trial has now completed recruitment, so are there results available yet, and how might those findings about surgical completeness change the way you would approach my care?
4Given that this research involved adnexal lesions and ovarian cancer risk, how does the quality or completeness of a salpingectomy factor into my specific situation and long-term ovarian cancer prevention?
5Are there standard-of-care guidelines already in place for salpingectomy in patients like me, and would the findings from this trial influence your recommendation compared to those existing guidelines?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Percentage of incomplete salpingectomies

Timeframe: 10 days

Trial details

NCT IDNCT05646680

SponsorUniversity Hospital, Ghent

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-04-12

View on ClinicalTrials.gov More Adnexal Lesion trials